NLRP3 and inflammatory bowel disease: In the study, it was found that calycosin can attenuate intestinal interstitial fibrosis and improve the inflammation status in TNBS-induced IBD model mice and, importantly, the effect of calycosin on expression of these fibrogenic factors was NLRP3-dependent.